Skip to main content Skip to main navigation menu Skip to site footer

Faktor yang mempengaruhi keterlambatan pengobatan kanker payudara: sebuah tinjauan sistematik



Abstract

Background: Breast cancer is cancer with a high global prevalence and high mortality rate. Several factors can affect the mortality rate and survival rate among breast cancer patients, one of which is the time it takes from diagnosis to receiving initial treatment. Delays in treatment can be caused by various factors, including patient, disease and system factors. This study aims to determine the causative factors of delay in breast cancer patients receiving treatment through a systematic review.

Method: This study is a systematic review study conducted by marshals the journals and critical appraisals of related publications from 2015-2020, published in the PubMed, Wiley Online Library and Sciencedirect database.

Results: Of the 126 related publications, an appraisal process was carried out to exclude unsuitable journals so that a total of 23 publications were analyzed in this study. Publications come from various countries, including the United States, Brazil, Mexico, Iran, China and Singapore. Based on these various literatures, it was found that the factors that could influence the delay in receiving treatment in breast cancer patients were black race, insurance ownership, low socio-economic level, low education level, lower cancer staging, and larger tumor size, indications for mastectomy surgery, the use of traditional medicines and the comorbidity of anxiety and depression.

Conclusion: Many factors cause the delay in receiving treatment in breast cancer patients. Further studies could be carried out to investigate the factors causing treatment delay in breast cancer patients.

 

 

Latar Belakang: Kanker payudara merupakan salah satu kanker dengan prevalensi global yang tinggi serta tingkat mortalitas yang tinggi. Berbagai hal dapat mempengaruhi tingkat mortalitas dan laju survival pada pasien kanker payudara, salah satunya adalah waktu yang dibutuhkan dari diagnosis hingga menerima pengobatan awal. Keterlambatan pengobatan dapat disebabkan oleh berbagai faktor diantaranya faktor pasien, penyakit serta sistem. Studi ini bertujuan untuk mengetahui faktor penyebab dari keterlambatan pasien kanker payudara dalam menerima pengobatan melalui tinjauan sistematik.

Metode: Studi ini merupakan studi tinjauan sistematik yang dilakukan dengan melakukan telaah jurnal dan critical appraisal terhadap publikasi terkait dari tahun 2015-2020 yang berada pada database PubMed, Wiley Online Library dan Sciencedirect.

Hasil: Dari 126 publikasi terkait yang ditemukan dilakukan proses appraisal untuk mengeklusi jurnal yang tidak sesuai sehingga didapatkan total 23 publikasi yang dianalisa dalam studi ini. Publikasi berasal dari berbagai negara diantaranya Amerika Serikat, Brazil, Mexico, Iran, Cina dan Singapore. Berdasarkan berbagai literatur tersebut ditemukan bahwa faktor yang dapat mempengaruhi terjadinya keterlambatan dalam menerima pengobatan pada pasien kanker payudara adalah ras kulit hitam, kepemilikan asuransi, tingkat sosial-ekonomi yang rendah, tingkat pendidikan yang rendah, staging kanker yang lebih rendah, ukuran tumor yang lebih besar, indikasi pembedahan mastektomi, penggunaan obat tradisional serta adanya komorbiditas kecemasan dan depresi.

Kesimpulan: Keterlambatan penerimaan pengobatan pada pasien kanker payudara disebabkan oleh banyak faktor. Studi lebih lanjut dapat dilakukan untuk menyelidiki faktor penyebab terjadinya keterlambatan pengobatan pada pasien kanker payudara.

Keywords: Keterlambatan Pengobatan Penyebab Kanker Payudara

References

  1. Ngowa JDK, Kabeyene A, Ngarvounsia R, Atenguena E, Tchawe YSN, Ngassam A, et al. Consultation, Diagnosis and Treatment Delays for Breast Cancer among Patients Followed up at the Yaoundé General Hospital, Cameron. Open Jounal of Obestetrics and Gynecology. 2020;10(11):1580-1589.
  2. Kumar A, Bhagabaty SM, Tripathy JP, Selvaraj K, Purkayastha J, Singh R. Delays in Diagnosis and Treatment of Breast Cancer and the Pathways of Care: A Mixed Methods Study from a Tertiary Cancer Centre in North East India. Asian Pac J Cancer Prev. 2019;20(12):3711-3721.
  3. Youn HJ, Han W. A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors. Asian Pac J Cancer Prev. 2020;21(4):867-880.
  4. Prabawa IPY, Bhargah A, Liwang F, Tandio DA, Tandio AL, Lestari AAW, Budiana ING, Manuaba IBAP. Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer. Asian Pac J Cancer Prev. 2019;20(3):863-868.
  5. Wiranata S, Anjani IAW, Saputra IPGS, Sadvika IGAS, Prabawa IPY, Supadmanaba IG, et al. Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as a Stage Determination in Breast Cancer. Open Access Maced J Med Sci. 2020;8(B):1058-1063.
  6. Kementerian Kesehatan Republik Indonesia. Situasi Penyakit Kanker di Indonesia. Pusdatin Kemenkes RI. Jakarta. 2015.
  7. Rivera-Franco MM, Leon-Rodriguez E. Delays in Breast Cancer Detection and Treatment in Developing Countries. Breast Cancer (Auckl). 2018;12:1-5.
  8. Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:1-11.
  9. Bleicher RJ, Chang C, Wang CE, Goldstein LJ, Kaufmann CS, Moran MS, et al. Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat. 2019;173(3):603-617.
  10. Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer. JAMA Oncol. 2016;2(3):322-329.
  11. Dedey F, Wu L, Ayettey H, Sanuade OA, Akingbola TS, Hewlett SA, et al. Factors Associated With Waiting Time for Breast Cancer Treatment in a Teaching Hospital in Ghana. Health Educ Behav. 2016;43(4):420-7.
  12. Takvorian SU, Oganisian A, Mamtani R, Mitra N, Shulman LN, Bekelman JE, et al. Association of Medicaid Expansion Under the Affordable Care Act With Insurance Status, Cancer Stage, and Timely Treatment Among Patients With Breast, Colon, and Lung Cancer. JAMA Netw Open. 2020;3(2):e1921653.
  13. Han X, Zhao J, Ruddy KJ, Lin CC, Sineshaw HM, Jemal A. The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women. PLoS One. 2018;13(6):e0198771.
  14. Andrade LSDS, Santos TTDM, de Oliveira MEC, Gomes KAL, Soares ARAP, de Oliveira TA, et al. Shorter delay to treatment by integrated diagnostic services and NGO- provided support among breast cancer patients in two Brazilian referral centres. J Public Health Res. 2021;10:2-30.
  15. Emerson MA, Golightly YM, Aiello AE, Reeder-Hayes KE, Tan X, Maduekwe U, et al. Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. Cancer. 2020;126(22):4957-4966.
  16. Reeder-Hayes KE, Mayer SE, Olshan AF, Wheeler SB, Carey LA, Tse CK, et al. Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study. Cancer. 2019;125(22):3985-3992.
  17. George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera EV, et al. Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt). 2015;24(3):209-17.
  18. He X, Ye F, Zhao B, Tang H, Wang J, Xiao X, et al. Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients. PLoS One. 2017;12(3):e0173862.
  19. Leon-Rodriguez E, Molina-Calzada C, Rivera-Franco MM, Campos-Castro A. Breast self-exam and patient interval associate with advanced breast cancer and treatment delay in Mexican women. Clin Transl Oncol. 2017;19(10):1276-1282.
  20. Grosse Frie K, Kamaté B, Traoré CB, Ly M, Mallé B, Coulibaly B, Wienke A, Kantelhardt EJ. Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali. PLoS One. 2018;13(11):e0207928.
  21. Johnson SB, Park HS, Gross CP, Yu JB. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. JAMA Oncol. 2018;4(10):1375-1381.
  22. Ferreira NAS, de Carvalho SMF, Valenti VE, Bezerra IMP, Batista HMT, de Abreu LC, et al. Treatment delays among women with breast cancer in a low socio-economic status region in Brazil. BMC Womens Health. 2017;17(1):1-8.
  23. Iglay K, Santorelli ML, Hirshfield KM, Williams JM, Rhoads GG, Lin Y, et al. Diagnosis and treatment delays among elderly breast cancer patients with pre-existing mental illness. Breast Cancer Res Treat. 2017;166(1):267-275.
  24. Ho PJ, Cook AR, Binte Mohamed Ri NK, Liu J, Li J, Hartman M. Impact of delayed treatment in women diagnosed with breast cancer: A population-based study. Cancer Med. 2020;9(7):2435-2444.
  25. Chukmaitov AS, Kaidarova DR, Talaeyva ST, Sheppard VB, Xu H, Siangphoe U, Ettner SL. Analysis of Delays in Breast Cancer Treatment and Late-Stage Diagnosis in Kazakhstan. Asian Pac J Cancer Prev. 2018;19(9):2519-2525.
  26. Khanjani N, Rastad H, Saber M, Khandani B, Travakkoli L. Causes of Delay in Seeking Treatment in Iranian Patients with Breast Cancer Based on the Health Belief Model (HBM). Int J Cancer Manag. 2018;11(6):1-10.
  27. Emerson MA. Race, Age and Treatment Delay In the Carolina Breast Cancer Study Phase 3 [Dissertation]. University of Carolina, Chapel Hill. 2019.
  28. Lee J, Jung JH, Kim WW, Park CS, Park HY. Patterns of Delaying Surgery for Breast Cancer During the COVID-19 Outbreak in Daegu, South Korea. Front Surg. 2020;7:1-7.
  29. Marijanovi? I, Pavlekovi? G, Buhovac T, Martinac M. The relationship between health locus of control, depression, and sociodemographic factors and amount of time breast cancer patients wait before seeking diagnosis and treatment. Psychiatr Danub. 2017;29(3):330-344.

How to Cite

Pratama, N. M. W., Wetan, N. G. A. A. M. Y., & Widiana, I. K. (2021). Faktor yang mempengaruhi keterlambatan pengobatan kanker payudara: sebuah tinjauan sistematik. Intisari Sains Medis, 12(1), 346–355. https://doi.org/10.15562/ism.v12i1.927
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
354

Total
343

Share

Search Panel

Ngakan Made Wirya Pratama
Google Scholar
Pubmed
ISM Journal

Ni Gusti Ayu Agung Manik Yuniawati Wetan
Google Scholar
Pubmed
ISM Journal

I Ketut Widiana
Google Scholar
Pubmed
ISM Journal